High cholesterol intake is associated with an increased risk of pancreatic cancer (116), and knockdown of LDLR in patients’ cells greatly reduces cholesterol uptake and alters its distribution, decreases cancer cell proliferation, and limits the activation of the ERK1/2 survival pathway. Here, LDLR is linked to familial pancreatic carcinoma.